| BMP | Bone morphogenetic protein |
| CAT | Catalase |
| CGRP | Calcitonin gene-related peptide |
| CFHR3 | Complement factor H-related protein 3 |
| CPN2 | Carboxypeptidase N catalytic chain |
| CRP | C-reactive protein |
| DD | Disc displacement |
| DDwR | Disc displacement with reduction |
| DDwoR | Disc displacement without reduction |
| dNLR | Derived NLR |
| ESR | Erythrocyte sedimentation rate |
| GCS | Glucosamine–chondroitin sulphate |
| HA | Hyaluronic acid |
| HMGB1 | High-mobility group box 1 |
| IASP | International Association for the Study of Pain |
| IFN-γ | Interferon-gamma |
| IL | Interleukin |
| iNOS | Inducible nitric oxide synthase |
| LLLT | Low-level laser therapy |
| LMR | Lymphocyte-to-monocyte ratio |
| MDA | Malondialdehyde |
| MMP | Matrix metalloproteinase |
| MMO | Maximum mouth opening |
| NLR | Neutrophil-to-lymphocyte ratio |
| OA | Osteoarthritis |
| OPN | Osteopontin |
| PGE2 | Prostaglandin E2 |
| PLR | Platelet-to-lymphocyte ratio |
| PRISMA | Preferred Reporting Items for Systematic Reviews and Meta-Analyses |
| PRP | Platelet-rich plasma |
| RDX | Radixin |
| RCT | Randomized controlled trial |
| SHA | Sodium hyaluronic acid |
| SII | Systemic immune-inflammation index |
| SOD | Superoxide dismutase |
| SS | Stabilization splint |
| TAC | Total antioxidant capacity |
| TLR4 | Toll-like receptor 4 |
| TMD | Temporomandibular disorders |
| TMJ | Temporomandibular joint |
| TMJ-ID | Temporomandibular joint internal derangement |
| TNF | Tumour necrosis factor |